CymaBay Therapeutics (NASDAQ:CBAY) reported quarterly losses of $(0.28) per share which beat the analyst consensus estimate of $(0.30) by 6.67 percent. This is a 15.15 percent increase over losses of $(0.33) per share from the same period last year.
Recap: NightHawk Biosciences Q2 Earnings
NightHawk Biosciences (AMEX:NHWK) reported its Q2 earnings results on Wednesday, August 10, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
